286 related articles for article (PubMed ID: 20688053)
1. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
Jung K; Fleischhacker M; Rabien A
Clin Chim Acta; 2010 Nov; 411(21-22):1611-24. PubMed ID: 20688053
[TBL] [Abstract][Full Text] [Related]
2. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.
Marzese DM; Hirose H; Hoon DS
Expert Rev Mol Diagn; 2013 Nov; 13(8):827-44. PubMed ID: 24127721
[TBL] [Abstract][Full Text] [Related]
6. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
7. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
Silva JM; Silva J; Sanchez A; Garcia JM; Dominguez G; Provencio M; Sanfrutos L; Jareño E; Colas A; España P; Bonilla F
Clin Cancer Res; 2002 Dec; 8(12):3761-6. PubMed ID: 12473587
[TBL] [Abstract][Full Text] [Related]
8. Circulating methylated DNA.
Herman JG
Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential of circulating nucleic acids for oncology.
Goessl C
Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
11. Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.
Hauser S; Zahalka T; Ellinger J; Fechner G; Heukamp LC; VON Ruecker A; Müller SC; Bastian PJ
Anticancer Res; 2010 Jul; 30(7):2785-9. PubMed ID: 20683013
[TBL] [Abstract][Full Text] [Related]
12. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
[TBL] [Abstract][Full Text] [Related]
13. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
Fleischhacker M; Schmidt B
Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
[TBL] [Abstract][Full Text] [Related]
14. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
15. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
16. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
17. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
[TBL] [Abstract][Full Text] [Related]
18. Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.
Spindler KG
Acta Oncol; 2017 Jan; 56(1):7-16. PubMed ID: 28010185
[TBL] [Abstract][Full Text] [Related]
19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
20. [Detection of free tumor-related DNA in the serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Deng GR
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
